IFNA1 and infection: Notably, the efficacy of PEG–IFN-α for the suppression of HBV was substantially blunted in HBV-HDV infection as compared with HBV mono-infection, especially at lower concentrations, but remained statistically significant at therapeutic doses (Figure 4C).